162 related articles for article (PubMed ID: 7521913)
1. Immunohistochemical demonstration of S100 protein in malignant melanomas of the facial skin and oral cavity.
Korabiowska M; Mirecka J; Brinck U; Szuta M; Stypulkowska J; Wiese G; Bartkowski S; Schauer A
J Nihon Univ Sch Dent; 1994 Jun; 36(2):117-21. PubMed ID: 7521913
[TBL] [Abstract][Full Text] [Related]
2. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
Mirecka J; Korabiowska M; Schauer A
Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
[TBL] [Abstract][Full Text] [Related]
3. S100, HMB-45, and Melan-A negative primary melanoma.
Shinohara MM; Deubner H; Argenyi ZB
Dermatol Online J; 2009 Sep; 15(9):7. PubMed ID: 19930994
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of S-100 protein and its subunits in melanotic lesions in the oral mucosa and skin.
Fujita S; Takahashi H; Tsuda N; Okabe H
J Oral Pathol Med; 1991 Oct; 20(9):429-32. PubMed ID: 1804988
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical profile of oral mucosal and head and neck cutaneous melanoma.
Alaeddini M; Etemad-Moghadam S
J Oral Pathol Med; 2015 Mar; 44(3):234-8. PubMed ID: 25048051
[TBL] [Abstract][Full Text] [Related]
6. Comparison of S-100 versus hematoxylin and eosin staining for evaluating dermal invasion and peripheral margins by desmoplastic malignant melanoma.
Eng W; Tschen JA
Am J Dermatopathol; 2000 Feb; 22(1):26-9. PubMed ID: 10698212
[TBL] [Abstract][Full Text] [Related]
7. An application of MIB antibody to the retrospective study of melanomas of oral mucosa and facial skin.
Korabiowska M; Brinck U; Hoenig JF; Bartkowski SB; Mirecka J; Schauer A
J Cancer Res Clin Oncol; 1994; 120(6):365-8. PubMed ID: 8138562
[TBL] [Abstract][Full Text] [Related]
8. Malignant combined squamomelanocytic tumor: a clinical case.
Wong D; Irimies A; Shkrum M; Joseph MG
Dermatol Online J; 2013 Sep; 19(9):19610. PubMed ID: 24050285
[TBL] [Abstract][Full Text] [Related]
9. Desmoplastic malignant melanoma of the oral mucosa. An underrecognized diagnostic pitfall.
Kilpatrick SE; White WL; Browne JD
Cancer; 1996 Aug; 78(3):383-9. PubMed ID: 8697380
[TBL] [Abstract][Full Text] [Related]
10. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.
Spanknebel K; Coit DG; Bieligk SC; Gonen M; Rosai J; Klimstra DS
Am J Surg Pathol; 2005 Mar; 29(3):305-17. PubMed ID: 15725798
[TBL] [Abstract][Full Text] [Related]
11. Selective lymph node dissection in patients with intermediate thickness melanoma: our experience.
Cafiero F; Peressini A; Percivale PL; Rainero ML; Faggioni M; Gipponi M; Queirolo P; Nicolo G; Bertoglio S
Anticancer Res; 2000; 20(1B):497-500. PubMed ID: 10769712
[TBL] [Abstract][Full Text] [Related]
12. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
13. Differences in tumor thickness between hematoxylin and eosin and Melan-A immunohistochemically stained primary cutaneous melanomas.
Drabeni M; Lopez-Vilaró L; Barranco C; Trevisan G; Gallardo F; Pujol RM
Am J Dermatopathol; 2013 Feb; 35(1):56-63. PubMed ID: 22688397
[TBL] [Abstract][Full Text] [Related]
14. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
[TBL] [Abstract][Full Text] [Related]
15. [Application of sentinel lymph node biopsy in patients with melanoma].
Ren M; Kong YY; Cai X; Shen XX; Lyu JJ
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):360-365. PubMed ID: 29783803
[No Abstract] [Full Text] [Related]
16. S100 protein and HMB-45 negative "rhabdoid" malignant melanoma: a totally dedifferentiated malignant melanoma?
Laskin WB; Knittel DR; Frame JN
Am J Clin Pathol; 1995 Jun; 103(6):772-3. PubMed ID: 7785665
[No Abstract] [Full Text] [Related]
17. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.
Ben-Izhak O; Stark P; Levy R; Bergman R; Lichtig C
Am J Dermatopathol; 1994 Jun; 16(3):241-6. PubMed ID: 7524376
[TBL] [Abstract][Full Text] [Related]
18. Localized multiple glomus tumors of the face and oral mucosa.
Yu HJ; Kwon SJ; Bahn JY; Park JM; Park YW
J Dermatol; 2000 Mar; 27(3):211-3. PubMed ID: 10774149
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
[TBL] [Abstract][Full Text] [Related]
20. A metastatic melanoma with an unusual immunophenotypic profile.
Gao Z; Stanek A; Chen S
Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
